|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 13
Zeitschriftenartikel
Wang, Shuaijun; Meixner, Maximilian; Yu, Lushuang; Zhuo, Ling; Karmann, Lisa; Kazmaier, Uli; Vollmar, Angelika M.; Antes, Iris und Zahler, Stefan
(2021):
Turning the Actin Nucleating Compound Miuraenamide into Nucleation Inhibitors.
In: ACS Omega, Bd. 6, Nr. 34: S. 22165-22172
Truebenbach, Ines; Zhang, Wei; Wang, Yanfang; Kern, Sarah; Hoehn, Miriam; Reinhard, Soeren; Gorges, Jan; Kazmaier, Uli und Wagner, Ernst
(2019):
Co-delivery of pretubulysin and siEG5 to EGFR overexpressing carcinoma cells.
In: International Journal of Pharmaceutics, Bd. 569, 118570
Wang, Shuaijun; Crevenna, Alvaro H.; Ugur, Ilke; Marion, Antoine; Antes, Iris; Kazmaier, Uli; Hoyer, Maria; Lamb, Don C.; Gegenfurtner, Florian; Kliesmetes, Zane; Ziegenhain, Christoph; Enard, Wolfgang; Vollmar, Angelika und Zahler, Stefan
(2019):
Actin stabilizing compounds show specific biological effects due to their binding mode.
In: Scientific Reports, Bd. 9, 9731
[PDF, 5MB]
Truebenbach, Ines; Kern, Sarah; Loy, Dominik M.; Hoehn, Miriam; Gorges, Jan; Kazmaier, Uli und Wagner, Ernst
(2019):
Combination Chemotherapy of L1210 Tumors in Mice with Pretubulysin and Methotrexate Lipo-Oligomer Nanoparticles.
In: Molecular Pharmaceutics, Bd. 16, Nr. 6: S. 2405-2417
Kern, Sarah; Truebenbach, Ines; Hoehn, Miriam; Gorges, Jan; Kazmaier, Uli; Zahler, Stefan; Vollmar, Angelika M. und Wagner, Ernst
(2019):
Combined antitumoral effects of pretubulysin and methotrexate.
In: Pharmacology Research & Perspectives, Bd. 7, Nr. 1, UNSP e00460
Koczian, Fabian; Naglo, Olga; Vomacka, Jan; Vick, Binje; Servatius, Phil; Zisis, Themistoklis; Hettich, Britta; Kazmaier, Uli; Sieber, Stephan A.; Jeremias, Irmela; Zahler, Stefan und Braig, Simone
(2019):
Targeting the endoplasmic reticulum-mitochondria interface sensitizes leukemia cells to cytostatics.
In: Haematologica, Bd. 104, Nr. 3: S. 546-555
Gegenfurtner, Florian A.; Zisis, Themistoklis; Al Danaf, Nader; Schrimpf, Waldemar; Kliesmete, Zane; Ziegenhain, Christoph; Enard, Wolfgang; Kazmaier, Uli; Lamb, Don C.; Vollmar, Angelika M. und Zahler, Stefan
(2018):
Transcriptional effects of actin-binding compounds: the cytoplasm sets the tone.
In: Cellular and Molecular Life Sciences, Bd. 75, Nr. 24: S. 4539-4555
Klein, Philipp Michael; Kern, Sarah; Lee, Dian-Jang; Schmaus, Johannes; Hoehn, Miriam; Gorges, Jan; Kazmaier, Uli und Wagner, Ernst
(2018):
Folate receptor-directed orthogonal click-functionalization of siRNA lipopolyplexes for tumor cell killing in vivo.
In: Biomaterials, Bd. 178: S. 630-642
Kappler, Sarah; Karmann, Lisa; Prudel, Cynthia; Herrmann, Jennifer; Caddeu, Giulia; Müller, Rolf; Vollmar, Angelika M.; Zahler, Stefan und Kazmaier, Uli
(2018):
Synthesis and Biological Evaluation of Modified Miuraenamides.
In: European Journal of Organic Chemistry, Nr. 48: S. 6952-6965
Moser, Christina; Rüdiger, Daniel; Foerster, Florian; Blume, Julia von; Yu, Peng; Kuster, Bernhard; Kazmaier, Uli; Vollmar, Angelika M. und Zahler, Stefan
(2017):
Persistent inhibition of pore-based cell migration by sub-toxic doses of miuraenamide, an actin filament stabilizer.
In: Scientific Reports, Bd. 7, 16407
[PDF, 1MB]
Trübenbach, Ines; Gorges, Jan; Kuhn, Jasmin; Kern, Sarah; Baratti, Emanuele; Kazmaier, Uli; Wagner, Ernst und Lächelt, Ulrich
(2017):
Sequence-Defined Oligoamide Drug Conjugates of Pretubulysin and Methotrexate for Folate Receptor Targeted Cancer Therapy.
In: Macromolecular Bioscience, Bd. 17, Nr. 10, 1600520
Eirich, Jürgen; Burkhart, Jens L.; Ullrich, Angelika; Rudolf, Georg C.; Vollmar, Angelika M.; Zahler, Stefan; Kazmaier, Uli und Sieber, Stephan A.
(2012):
Pretubulysin derived probes as novel tools for monitoring the microtubule network via activity-based protein profiling and fluorescence microscopy.
In: Molecular BioSystems, Bd. 8, Nr. 8: S. 2067-2075
[PDF, 3MB]
Herrmann, Jennifer; Elnakady, Yasser A.; Wiedmann, Romina M.; Ullrich, Angelika; Rohde, Manfred; Kazmaier, Uli; Vollmar, Angelika M. und Müller, Rolf
(2012):
Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy.
In: PLOS ONE 7(5), e37416 [PDF, 1MB]
In: PLOS ONE 7(5), e37416 [PDF, 1MB]